CS175500B2 - - Google Patents

Info

Publication number
CS175500B2
CS175500B2 CS215A CS21576A CS175500B2 CS 175500 B2 CS175500 B2 CS 175500B2 CS 215 A CS215 A CS 215A CS 21576 A CS21576 A CS 21576A CS 175500 B2 CS175500 B2 CS 175500B2
Authority
CS
Czechoslovakia
Application number
CS215A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS175500B2 publication Critical patent/CS175500B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CS215A 1974-08-05 1975-07-22 CS175500B2 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CS175500B2 true CS175500B2 (OSRAM) 1977-05-31

Family

ID=5922668

Family Applications (2)

Application Number Title Priority Date Filing Date
CS215A CS175500B2 (OSRAM) 1974-08-05 1975-07-22
CS5170A CS175498B2 (OSRAM) 1974-08-05 1975-07-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS5170A CS175498B2 (OSRAM) 1974-08-05 1975-07-22

Country Status (17)

Country Link
US (1) US4029777A (OSRAM)
JP (1) JPS5141347A (OSRAM)
AT (1) AT345998B (OSRAM)
BE (1) BE832124A (OSRAM)
CA (1) CA1037027A (OSRAM)
CH (1) CH611910A5 (OSRAM)
CS (2) CS175500B2 (OSRAM)
DD (1) DD120192A5 (OSRAM)
DE (1) DE2438020A1 (OSRAM)
DK (1) DK136369C (OSRAM)
ES (1) ES439720A1 (OSRAM)
FR (1) FR2281123A1 (OSRAM)
GB (1) GB1512258A (OSRAM)
HU (1) HU171684B (OSRAM)
IL (1) IL47770A (OSRAM)
NL (1) NL7509326A (OSRAM)
SE (1) SE404804B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス, インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX384728B (es) 2014-10-16 2025-03-14 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
EP4442695A3 (en) * 2017-12-22 2025-01-22 Sage Therapeutics, Inc. 19-homo, 3.alpha.-hydroxy-steroid-20-one compounds for treating cns disorders
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
DK136369B (da) 1977-10-03
HU171684B (hu) 1978-02-28
GB1512258A (en) 1978-05-24
IL47770A0 (en) 1975-10-15
ES439720A1 (es) 1977-03-01
AT345998B (de) 1978-10-10
CH611910A5 (OSRAM) 1979-06-29
NL7509326A (nl) 1976-02-09
ATA600475A (de) 1978-02-15
DK136369C (da) 1978-02-27
CA1037027A (en) 1978-08-22
SE404804B (sv) 1978-10-30
SE7508777L (sv) 1976-02-06
DK344475A (da) 1976-02-06
IL47770A (en) 1978-10-31
BE832124A (fr) 1976-02-05
FR2281123A1 (fr) 1976-03-05
JPS5141347A (en) 1976-04-07
US4029777A (en) 1977-06-14
DD120192A5 (OSRAM) 1976-06-05
AU8351575A (en) 1977-02-03
DE2438020A1 (de) 1976-02-26
CS175498B2 (OSRAM) 1977-05-31

Similar Documents

Publication Publication Date Title
CS175498B2 (OSRAM)
FR2257123B1 (OSRAM)
DK135229C (OSRAM)
FI753372A7 (OSRAM)
FI750676A7 (OSRAM)
AU495883B2 (OSRAM)
FI750508A7 (OSRAM)
AU7891375A (OSRAM)
AU495028B2 (OSRAM)
AU495821B2 (OSRAM)
DK82975A (OSRAM)
CS172044B1 (OSRAM)
CS173899B1 (OSRAM)
BG19634A1 (OSRAM)
DD125491A5 (OSRAM)
BG19730A1 (OSRAM)
BG19726A1 (OSRAM)
BG19703A1 (OSRAM)
BG19965A1 (OSRAM)
BG19624A1 (OSRAM)
BG19620A1 (OSRAM)
BG19614A1 (OSRAM)
BG20001A1 (OSRAM)
BG20049A1 (OSRAM)
BG19759A1 (OSRAM)